Nitric oxide, a protective molecule in the cardiovascular system

Nitric Oxide - Biology and Chemistry

Volumn 35, Issue , 2013, Pages 175-185

  Lei, Jing ^a   Vodovotz, Yoram ^a   Tzeng, Edith ^a   Billiar, Timothy R ^a  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Blood vessel injury; Endothelial cell; Intimal hyperplasia; Nitric oxide; Smooth muscle cell; Transplant vasculopathy

Indexed keywords

ADENOVIRUS VECTOR; ANGIOTENSIN 1 RECEPTOR; CD11B ANTIGEN; COLLAGENASE 3; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DEOXYHEMOGLOBIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; GELATINASE A; GELATINASE B; GUANYLATE CYCLASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; N(G),N(G) DIMETHYLARGININE; NEURONAL NITRIC OXIDE SYNTHASE; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN P53; RAPAMYCIN; STROMELYSIN; SUPEROXIDE DISMUTASE; TACROLIMUS; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; CARDIOVASCULAR AGENT; NITRIC OXIDE; PROTECTIVE AGENT;

APOPTOSIS; ARTERIAL WALL THICKNESS; ARTERY BLOOD FLOW; ARTICLE; BIOAVAILABILITY; BLOOD VESSEL INJURY; CARDIAC ALLOGRAFT ARTERIOSCLEROSIS; CARDIAC GRAFT REJECTION; CARDIOVASCULAR SYSTEM; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; EX VIVO STUDY; EXTRACELLULAR MATRIX; HEART CONTRACTION; HEART PROTECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INTIMAL HYPERPLASIA; LEUKOCYTE ADHERENCE; MONOCYTE; NITRATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STEM CELL; SYNAPTIC TRANSMISSION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; UPREGULATION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL; CELL ADHESION; CYTOLOGY; DRUG EFFECTS; MOUSE; PHYSIOLOGY;

ANIMALS; CARDIOVASCULAR AGENTS; CELL ADHESION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MICE; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE; PLATELET AGGREGATION; PROTECTIVE AGENTS;

EID: 84887206478     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2013.09.004     Document Type: Review

References (203)

1. D.S. Bredt, and S.H. Snyder Nitric oxide, a physiological messenger molecule Annu. Rev. Biochem. 63 1994 175 195
2. C. Nathan Nitric oxide as a secretory product of mammalian cells FASEB J. 6 1992 3051 3064
3. C. Nathan Natural resistance and nitric oxide Cell 82 1995 873 876
4. S. Moncada, and A. Higgs Mechanisms of diseases: the l-arginine-nitric oxide pathway N. Engl. J. Med. 329 1993 2002 2012 (Pubitemid 24015045)
5. G. Kojda, and K. Kottenberg Regulation of basal myocardial function by NO Cardiovasc. Res. 41 3 1999 514 523 Review (Pubitemid 29130615)
6. C. Nathan, and Q.W. Xie Nitric oxide synthase: roles, tolls, and controls Cell 78 1994 915 Review
7. D.A. Geller, A.K. Nussler, M. Di Silvio, C.J. Lowenstein, R.A. Shapiro, S.C. Wang, R.L. Simmons, and T.R. Billiar Cytokines endotoxin glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes Proc. Natl. Acad. Sci. USA 90 1993 522
8. S.M. Morris Jr., and T.R. Billiar New insights into the regulation of inducible nitric oxide synthesis Am. J. Physiol. 266 6 Pt 1 1994 E829 E839 Review
9. A.K. Nussler, and T.R. Billiar Inflammation, immunoregulation, and inducible nitric oxide synthase J. Leukoc. Biol. 171 1993 54
10. 2 promoter Proc. Natl. Acad. Sci. USA 93 1996 1054
11. H.M. Abu-Soud, and D.J. Stuehr Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer Proc. Natl. Acad. Sci. USA 90 22 1993 10769 10772 (Pubitemid 23347124)
12. J. Wang, D.J. Stuehr, M. Ikeda-Saito, and D.L. Rousseau Heme coordination and structure of the catalytic site in nitric oxide synthase J. Biol. Chem. 268 30 1993 22255 22258 (Pubitemid 23318263)
13. U.C. Garg, and A. Hassid Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells J. Clin. Invest. 83 1989 1774 1777 (Pubitemid 19124139)
14. T.L. Cornwell, E. Arnold, N.J. Boerth, and T.M. Lincoln Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP Am. J. Physiol. 267 1994 C1405 C1413
15. J. Guo, M. Panday, P. Counsigny, and A. Lefer Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury Am. J. Physiol. 1995 H1122 H1131
16. R.K. Dubey, E.K. Jackson, and T.F. Luscher Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin-1 receptors J. Clin. Invest. 96 1995 141 149
17. R. Sarkar, E.G. Meinberg, J.C. Stanley, D. Gordon, and R.C. Webb Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells Circ. Res. 78 1996 225 230 (Pubitemid 26042839)
18. M. Ziche, L. Morbidelli, E. Masini, S. Amerini, H.J. Granger, C.A. Maggi, P. Geppetti, and F. Ledda Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P J. Clin. Invest. 94 5 1994 2036 2044 (Pubitemid 24348244)
19. E. Tzeng, T.R. Billiar, D.L. Williams, J. Li, A. Lizonova, I. Kovesdi, and Y.M. Kim Adenovirus-mediated inducible nitric oxide synthase gene transfer inhibits hepatocyte apoptosis Surgery 124 2 1998 278 283 (Pubitemid 28372927)
20. B.T. Mellion, L.J. Ignarro, C.B. Myers, E.H. Ohlstein, B.A. Ballot, A.L. Hyman, and P.J. Kadowitz Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation Mol. Pharmacol. 23 3 1983 653 664 (Pubitemid 13089783)
21. T.B. McCall, N.K. Boughton-Smith, R.M. Palmer, B.J. Whittle, and S. Moncada Synthesis of nitric oxide from l-arginine by neutrophils. Release and interaction with superoxide anion Biochem. J. 261 1 1989 293 296 (Pubitemid 19174794)
22. M.W. Radomski, R.M. Palmer, and S. Moncada Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium Lancet 2 8567 1987 1057 1058 (Pubitemid 17154788)
23. Z.Q. Yan, T. Yokota, W. Zhang, and G.K. Hansson Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery Circ. Res. 79 1 1996 38 44
24. P. Kubes, M. Suzuki, and D.N. Granger Nitric oxide: an endogenous modulator of leukocyte adhesion Proc. Natl. Acad. Sci. USA 88 1991 4651
25. M. Suzuki, W. Inauen, P.R. Kvietys, M.B. Grisham, C. Meininger, M.E. Schelling, H.J. Granger, and D.N. Granger Superoxide mediates reperfusion-induced leukocyte-endothelial cell interactions Am. J. Physiol. 257 5 Pt 2 1989 H1740 H1745
26. M.J. Hickey, K.A. Sharkey, E.G. Sihota, P.H. Reinhardt, J.D. Macmicking, C. Nathan, and P. Kubes Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia FASEB J. 11 12 1997 955 964 (Pubitemid 27425897)
27. H.B. Peng, M. Spiecker, and J.K. Liao Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation J. Immunol. 161 4 1998 1970 1976 (Pubitemid 28387621)
28. J. Fingerle, R. Johnson, A.W. Clowes, M.W. Majesky, and M.A. Reidy Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery Proc. Natl. Acad. Sci. USA 86 21 1989 8412 8416 (Pubitemid 19286068)
29. R.P. McEver, and R.D. Cummings Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment J. Clin. Invest. 100 3 1997 485 491
30. T.G. Diacovo, A.R. DeFougerolles, D.F. Bainton, and T.A. Springer A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2 J. Clin. Invest. 94 3 1994 1243 1251 (Pubitemid 24286469)
31. T.G. Diacovo, S.J. Roth, J.M. Buccola, D.F. Bainton, and T.A. Springer Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18 Blood 88 1 1996 146 157 (Pubitemid 26230682)
32. R. Ross, J. Glomset, B. Kariya, and L. Harker A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro Proc. Natl. Acad. Sci. USA 71 4 1974 1207 1210
33. R. Ross George lyman duff memorial lecture. Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components Arteriosclerosis 1 5 1981 293 311 (Pubitemid 12201806)
34. A.K. Mitra, M.G. Del Core, and D.K. Agrawal Cells cytokines and cellular immunity in the pathogenesis of fibroproliferative vasculopathies Can. J. Physiol. Pharmacol. 83 8-9 2005 701 715 (Pubitemid 41784009)
35. J. Suzuki, M. Aikawa, M. Isobe, M. Sekiguchi, Y. Yazaki, and R. Nagai Altered expression of smooth muscle and non-muscle myosin heavy chain isoforms in rejected hearts: a sensitive marker for acute rejection and graft coronary arteriosclerosis Transplant. Proc. 27 1 1995 578
36. J. Suzuki, M. Isobe, M. Aikawa, M. Kawauchi, I. Shiojima, N. Kobayashi, A. Tojo, T. Suzuki, K. Kimura, T. Nishikawa, T. Sakai, M. Sekiguchi, Y. Yazaki, and R. Nagai Nonmuscle and smooth muscle myosin heavy chain expression in rejected cardiac allografts. A study in rat and monkey models Circulation 94 5 1996 1118 1124 (Pubitemid 26292869)
37. M.G. Davies, and P.O. Hagen Pathobiology of intimal hyperplasia Br. J. Surg. 81 9 1994 1254 1269 (Pubitemid 24275140)
38. P. Libby, G. Sukhova, R.T. Lee, and J.K. Liao Molecular biology of atherosclerosis Int. J. Cardiol. 31 62 Suppl. 2 1997 S23 S29
39. S.M. Schwartz Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis J. Clin. Invest. 99 12 1997 2814 2816
40. P.L. Faries, M.L. Marin, F.J. Veith, J.A. Ramirez, W.D. Suggs, R.E. Parsons, L.A. Sanchez, and R.T. Lyon Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimental model J. Vasc. Surg. 24 3 1996 463 471 (Pubitemid 26349813)
41. H. Tanaka, S.J. Swanson, G. Sukhova, F.J. Schoen, and P. Libby Smooth muscle cells of the coronary arterial tunica media express tumor necrosis factor-alpha and proliferate during acute rejection of rabbit cardiac allografts Am. J. Pathol. 147 3 1995 617 626
42. U. Ikeda, M. Ikeda, T. Oohara, S. Kano, and T. Yaguinuma Mitogenic action of interleukin-1β on vascular smooth muscle cells mediated by PDGF Atherosclerosis 84 1990 183 188 (Pubitemid 20360863)
43. T.J. Nathe, J. Deou, B. Walsh, B. Bourns, A.W. Clowes, and G. Daum Interleukin-1beta inhibits expression of p21(WAF1/CIP1) and p27(KIP1) and enhances proliferation in response to platelet-derived growth factor-BB in smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 22 8 2002 1293 1298 (Pubitemid 34875739)
44. D.R. Clemmons Interaction of circulating cell-derived and plasma growth factors in stimulating plasma smooth muscle cell replication J. Cell. Physiol. 121 1984 425
45. B. Pfeifle, and H. Ditschuneit Binding and biological actions of insulin-like growth factors on human smooth muscle cells Horm. Metab. Res. 14 1982 409
46. Y. Fujiwara, and T. Kaji Zinc potentiates the stimulation by basic and acidic fibroblast growth factors on the proliferation of cultured vascular smooth muscle cells Res. Commun. Mol. Pathol. Pharmacol. 97 1 1997 95 106 (Pubitemid 27362633)
47. V. Lindner, D.A. Lappi, A. Baird, R.A. Majack, and M.A. Reidy Role of basic fibroblast growth factor in vascular lesion formation Circ. Res. 68 1 1991 106 113
48. Z. Chen, F.Y. Lee, K.N. Bhalla, and J. Wu Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib) Mol. Pharmacol. 69 5 2006 1527 1533 Epub 2006 Jan 25
49. A. Jawien, D.F. Bowen-Pope, V. Lindner, S.M. Schwartz, and A.W. Clowes Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty J. Clin. Invest. 89 2 1992 507 511
50. N. Motomura, H. Lou, P. Maurice, and M.L. Foegh Acceleration of arteriosclerosis of the rat aorta allograft by insulin growth factor-I Transplantation 63 7 1997 932 936 (Pubitemid 27173012)
51. R.A. Wolff, M. Ryomoto, V.E. Stark, R. Malinowski, J.J. Tomas, M.A. Stinauer, D.A. Hullett, and J.R. Hoch Antisense to transforming growth factor-beta1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1 J. Vasc. Surg. 41 3 2005 498 508 (Pubitemid 40523595)
52. C.H. Selzman, B.D. Shames, and L.L. Reznikov Liposomal delivery of purified inhibitory-κBα inhibits tumor necrosis factor-α- induced human vascular smooth muscle proliferation Circ. Res. 84 1999 867 875 (Pubitemid 29196730)
53. M.A. Zimmerman, C.H. Selzman, L.L. Reznikov, S.A. Miller, C.D. Raeburn, J. Emmick, X. Meng, and A.H. Harken Lack of TNF-alpha attenuates intimal hyperplasia after mouse carotid artery injury Am. J. Physiol. Regul. Integr. Comp. Physiol. 283 2 2002 R505 R512
54. D.G. Neschis, S.D. Safford, A.K. Hanna, J.C. Fox, and M.A. Golden Antisense basic fibroblast growth factor gene transfer reduces early intimal thickening in a rabbit femoral artery balloon injury model J. Vasc. Surg. 27 1 1998 126 134 (Pubitemid 28081168)
55. A.W. Clowes, M.M. Clowes, and M.A. Reidy Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels Lab. Invest. 54 3 1986 295 303 (Pubitemid 16051572)
56. D. Hasenstab, R. Forough, and A.W. Clowes Plasminogen activator inhibitor type 1 and tissue inhibitor of metalloproteinases-2 increase after arterial injury in rats Circ. Res. 80 4 1997 490 496 (Pubitemid 27137285)
57. M.P. Bendeck, N. Zempo, A.W. Clowes, R.E. Galardy, and M.A. Reidy Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat Circ. Res. 75 3 1994 539 545 (Pubitemid 24256415)
58. D.B. McNamara, B. Bedi, and H. Aurora l-Arginine inhibits balloon catheter-induced intimal hyperplasia Biochem. Biophys. Res. Commun. 193 1993 291 296 (Pubitemid 23199945)
59. J.P. Guo, K.A. Milhoan, R.S. Tuan, and A.M. Lefer Beneficial effect of SPM-5185, a cysteine-containing nitric oxide donor, in rat carotid artery intimal injury Circ. Res. 75 1 1994 77 84
60. D.S. Marks, J.A. Vita, and J.D. Folts Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide J. Clin. Invest. 96 1995 2630 2638
61. P.H. Groves, A.P. Banning, and W.J. Penny The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty Cardiovasc. Res. 30 1995 87 96
62. J.P. Guo, M.M. Panday, P.M. Consigny, and A.M. Lefer Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury Am. J. Physiol. Heart Circ. Physiol. 269 1995 H1122 H1131
63. J.S. Lee, C. Adrie, and H.J. Jacob Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury Circ. Res. 78 1996 337 342 (Pubitemid 26040862)
64. E. Tzeng, L.L. Shears, P.D. Robbins, B.R. Pitt, D.A. Geller, S.C. Watkins, R.L. Simmons, and T.R. Billiar Vascular gene transfer of the human inducible nitric oxide synthase: characterization of activity and effects on myointimal hyperplasia Mol. Med. 2 1996 211 225 (Pubitemid 26421991)
65. L.L. Shears 2nd, M.R. Kibbe, A.D. Murdock, T.R. Billiar, A. Lizonova, I. Kovesdi, S.C. Watkins, and E. Tzeng Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo J. Am. Coll. Surg. 187 3 1998 295 306 (Pubitemid 28433437)
66. R. Cooney, S.O. Hynes, F. Sharif, L. Howard, and T. O'Brien Effect of gene delivery of NOS isoforms on intimal hyperplasia and endothelial regeneration after balloon injury Gene Ther. 14 5 2007 396 404 Epub 2006 Nov 2
67. T. Pfeiffer, M. Wallich, W. Sandmann, J. Schrader, and A. Gödecke Lipoplex gene transfer of inducible nitric oxide synthase inhibits the reactive intimal hyperplasia after expanded polytetrafluoroethylene bypass grafting J. Vasc. Surg. 43 5 2006 1021 1027
68. M.R. Kibbe, E. Tzeng, S.L. Gleixner, S.C. Watkins, I. Kovesdi, A. Lizonova, M.S. Makaroun, T.R. Billiar, and R.Y. Rhee Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia J. Vasc. Surg. 34 1 2001 156 165 (Pubitemid 33660705)
69. P.C. Lee, Z.L. Wang, S. Qian, S.C. Watkins, A. Lizonova, I. Kovesdi, E. Tzeng, R.L. Simmons, T.R. Billiar, and L.L. Shears 2nd Endothelial nitric oxide synthase protects aortic allografts from the development of transplant arteriosclerosis Transplantation 69 6 2000 1186 1192 (Pubitemid 30217604)
70. L.L. Shears, N. Kawaharada, E. Tzeng, T.R. Billiar, S.C. Watkins, I. Kovesdi, A. Lizonova, and S.M. Pham Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis J Clin Invest. 100 8 1997 2035 2042 (Pubitemid 27459358)
71. G.J. Fulton, M.G. Davies, L. Barber, J.L. Gray, E. Svendsen, and P.O. Hagen Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts Eur. J. Vasc. Endovasc. Surg. 15 4 1998 279 289 (Pubitemid 28205985)
72. A. Chaux, X.M. Ruan, M.C. Fishbein, Y. Ouyang, S. Kaul, J.A. Pass, and J.M. Matloff Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation J. Thorac. Cardiovasc. Surg. 115 3 1998 604 612
73. M.R. Kibbe, S. Nie, T. Yoneyama, K. Hatakeyama, A. Lizonova, I. Kovesdi, T.R. Billiar, and E. Tzeng Optimization of ex vivo inducible nitric oxide synthase gene transfer to vein grafts Surgery 126 2 1999 323 329 (Pubitemid 29382798)
74. M.H. Kown, M.A. Lijkwan, C.L. Jahncke, S. Murata, J.B. Rothbard, and R.C. Robbins l-Arginine polymers enhance coronary flow and reduce oxidative stress following cardiac transplantation in rats J. Thorac. Cardiovasc. Surg. 126 4 2003 1065 1070 (Pubitemid 37305691)
75. N.E. West, H. Qian, T.J. Guzik, E. Black, S. Cai, S.E. George, and K.M. Channon Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production Circulation 104 13 2001 1526 1532 (Pubitemid 32917346)
76. A. Iwata, S. Sai, M. Moore, J. Nyhuis, R. de Fries-Hallstrand, G.C. Quetingco, and M.D. Allen Gene therapy of transplant arteriopathy by liposome-mediated transfection of endothelial nitric oxide synthase J. Heart Lung Transplant. 19 11 2000 1017 1028
77. B. Meiser, and B. Reichart Graft vessel disease: the impact of immunosuppression and possible treatment strategies Immunol. Rev. 134 1993 99 116 (Pubitemid 23284210)
78. S. Kerber, A. Rahmel, O. Heinemann-Vechtel, T. Budde, M. Deng, H.H. Scheld, and G. Breithardt Angiographic, intravascular ultrasound and functional findings early after orthotopic heart transplantation Int. J. Cardiol. 49 2 1995 119 129
79. M.R. Mehra, H.O. Ventura, F.W. Smart, D.D. Stapleton, T.J. Collins, S.R. Ramee, J.P. Murgo, and C.J. White New developments in the diagnosis and management of cardiac allograft vasculopathy Tex. Heart Inst. J. 22 2 1995 138 144
80. A. Ardehali Heart transplantation: accelerated graft atherosclerosis Adv. Card. Surg. 6 1995 195 205
81. H.O. Ventura, F.W. Smart, D.D. Stapleton, T. Toups, and H.L. Price Cardiac allograft vasculopathy: current concepts J. Louisiana State Med. Soc. 145 5 1993 195 198 200-202
82. H.O. Ventura, M.R. Mehra, F.W. Smart, and D.D. Stapleton Cardiac allograft vasculopathy: current concepts Am. Heart J. 129 4 1995 791 799
83. J.M. Kriett, and M.P. Kaye The registry of the international society for heart and lung transplantation: eighth official report J. Heart Lung Transplant. 10 1991 491
84. P.L. Turek In Support and Replacement of the Failing Heart Frazier OH 1996 Lippincott-Raven Philadelphia, Penn p. 261
85. H. Tanaka, S.J. Swanson, G. Sukhova, F.J. Schoen, and P. Libby Early proliferation of medial smooth muscle cells in coronary arteries of rabbit cardiac allografts during immunosuppression with cyclosporine A Transpl. Proc. 27 3 1995 2062 2065
86. A. Dhaliwal, and V. Thohan Cardiac allograft vasculopathy: the Achilles' heel of long-term survival after cardiac transplantation Curr. Atheroscler. Rep. 8 2 2006 119 130
87. M.E. Billingham Cardiac transplant atherosclerosis Transplant. Proc. 4 Suppl. 5 1987 19 25 (Pubitemid 17151768)
88. B. Radovancevic, S. Birovljev, J.D. Vega, J.L. Lonquist, M.S. Sweeney, J.D. Vasiljevic, C.T. Van Buren, R.H. Kerman, and O.H. Frazier Inverse relationship between human leukocyte antigen match and development of coronary artery disease Transplant. Proc. 23 1 Pt 2 1991 1144 1145
89. M.R. Costanzo-Nordin Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility J. Heart Lung Transplant. 11 3 Pt 2 1992 S90 S103
90. E.H. Hammond, R.L. Yowell, G.D. Price, R.L. Menlove, S.L. Olsen, J.B. O'Connell, M.R. Bristow, D.B. Doty, R.C. Millar, and S.V. Karwande Vascular rejection and its relationship to allograft coronary artery disease J. Heart Lung Transplant. 11 3 Pt 2 1992 S111 S119
91. B.F. Uretsky, S. Murali, P.S. Reddy, B. Rabin, A. Lee, B.P. Griffith, R.L. Hardesty, A. Trento, and H.T. Bahnson Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone Circulation 76 4 1987 827 834 (Pubitemid 17151341)
92. A. Schütz, B.M. Kemkes, C. Kugler, C. Angermann, N. Schad, R. Rienmüller, S. Fritsch, M. Anthuber, P. Neumaier, and J.M. Gokel The influence of rejection episodes on the development of coronary artery disease after heart transplantation Eur. J. Cardiothorac. Surg. 4 6 1990 300 307 discussion 308
93. M.R. Mehra, H.O. Ventura, R. Chambers, T.J. Collins, S.R. Ramee, M.A. Kates, F.W. Smart, and D.D. Stapleton Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study J. Am. Coll. Cardiol. 26 6 1995 1537 1544
94. H. Gohra, T.O. McDonald, E.D. Verrier, and S. Aziz Endothelial loss and regeneration in a model of transplant arteriosclerosis Transplantation 60 1 1995 96 102
95. M.T. Grattan, C.E. Moreno-Cabral, V.A. Starnes, P.E. Oyer, E.B. Stinson, and N.E. Shumway Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis JAMA 261 24 1989 23 30 3561-3566
96. M. Weis, T.N. Kledal, K.Y. Lin, S.N. Panchal, S.Z. Gao, H.A. Valantine, E.S. Mocarski, and J.P. Cooke Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis Circulation 109 4 2004 500 505 Epub 2004 Jan 19 (Pubitemid 38168513)
97. M.R. Costanzo, D.C. Naftel, M.R. Pritzker, J.K. Heilman 3rd, J.P. Boehmer, S.C. Brozena, G.W. Dec, H.O. Ventura, J.K. Kirklin, R.C. Bourge, and L.W. Miller Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database J. Heart Lung Transplant. 17 8 1998 744 753 (Pubitemid 28396983)
98. P.R. Rickenbacher, M.S. Kemna, F.J. Pinto, S.A. Hunt, E.L. Alderman, J.S. Schroeder, E.B. Stinson, R.L. Popp, I. Chen, G. Reaven, and H.A. Valantine Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary untrasound study of immunologic and metabolic risk factors Transplantation 61 1 1996 46 53 (Pubitemid 26033377)
99. J.A. Kobashigawa, S. Katznelson, H. Laks, J.A. Johnson, L. Yeatman, X.M. Wang, D. Chia, P.I. Terasaki, A. Sabad, and G.A. Cogert Effect of pravastatin on outcomes after cardiac transplantation N. Engl. J. Med. 333 10 1995 621 627
100. P.B. Berger, J.D. Jones, L.J. Olson, B.S. Edwards, R.P. Frantz, R.J. Rodeheffer, B.A. Kottke, R.C. Daly, and C.G. McGregor Increase in total plasma homocysteine concentration after cardiac transplantation Mayo Clin. Proc. 70 2 1995 125 131
101. M. Arnadottir, B. Hultburg, V. Vladov, P. Nilsson-Ehle, and H. Thysell Hyperhomocysteinemia in cyclosporing-treated renal transplant recipients Transplantation 61 3 1996 509 512 (Pubitemid 26067934)
102. P. Ambrosi, D. Garçon, A. Riberi, G. Habib, A. Barlatier, B. Kreitmann, P.H. Rolland, G. Bouvenot, R. Luccioni, and D. Métras Association of mild hyperhomocysteinemia with cardiac graft vascular disease Atherosclerosis 138 2 1998 347 350 (Pubitemid 28313519)
103. A. Gupta, A. Moustapha, D.W. Jacobsen, M. Goormastic, E.M. Tuzcu, R. Hobbs, J. Young, K. James, P. McCarthy, F. van Lente, R. Green, and K. Robinson High homocysteine, low folate, and low vitamin B6 concentrations: prevalent risk factors for vascular disease in heart transplant recipients Transplantation 65 4 1998 544 550
104. H. Valantine, P. Rickenbacker, M. Kemna, S. Hunt, Y.D. Chen, G. Reaven, and E.B. Stinson Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease: a prospective study Circulation 103 17 2001 2144 2152 (Pubitemid 32458323)
105. D. Ramzy, V. Rao, J. Brahm, S. Miriuka, D. Delgado, and H.J. Ross Cardiac allograft vasculopathy: a review Can. J. Surg. 48 4 2005 319 327 (Pubitemid 41297336)
106. B.S. Rabin, B.P. Griffith, and R.L. Hardesty Vascular endothelial cell HLA-DR antigen and myocyte necrosis in human allograft rejection J. Heart Transplant. 4 3 1985 293 295
107. J.D. Day, B.K. Rayburn, P.B. Gaudin, W.M. Baldwin 3rd, C.J. Lowenstein, E.K. Kasper, K.L. Baughman, W.A. Baumgartner, G.M. Hutchins, and R.H. Hruban Cardiac allograft vasculopathy: the central pathogenetic role of ischemia-induced endothelial cell injury J. Heart Lung Transplant. 14 6 Pt 2 1995 S142 S149
108. D. Behrendt, P. Ganz, and J.C. Fang Cardiac allograft vasculopathy Curr. Opin. Cardiol. 15 6 2000 422 429
109. C.A. Labarrere, D.R. Nelson, S.J. Miller, J.M. Nieto, J.A. Conner, D.E. Pitts, P.C. Kirlin, and H.G. Halbrook Value of serum-soluble intercellular adhesion molecule-1 for the noninvasive risk assessment of transplant coronary artery disease, posttransplant ischemic events, and cardiac graft failure Circulation 102 13 2000 1549 1555
110. K. Okada, Y. Nishida, H. Murakami, I. Sugimoto, H. Kosaka, H. Morita, C. Yamashita, and M. Okada Role of endogenous endothelin in the development of graft arteriosclerosis in rat cardiac allografts: antiproliferative effects of bosentan, a nonselective endothelin receptor antagonist Circulation 97 23 1998 2346 2351 (Pubitemid 28280389)
111. A. Yamaguchi, D.N. Miniati, K. Hirata, E.G. Hoyt, and R.C. Robbins Ex vivo blockade of endothelin-1 inhibits graft coronary artery disease in a rodent cardiac allograft model J. Heart Lung Transplant. 21 4 2002 417 424 (Pubitemid 34240462)
112. P. Calabró, J.T. Willerson, and E.T. Yeh Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells Circulation 108 16 2003 1930 1932 Epub 2003 Oct 6 (Pubitemid 37296536)
113. S. Verma, C.H. Wang, S.H. Li, A.S. Dumont, P.W. Fedak, M.V. Badiwala, B. Dhillon, R.D. Weisel, R.K. Li, D.A. Mickle, and D.J. Stewart A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis Circulation 106 8 2002 913 919 (Pubitemid 34925323)
114. C.H. Wang, S.H. Li, R.D. Weisel, P.W. Fedak, A.S. Dumont, P. Szmitko, R.K. Li, D.A. Mickle, and S. Verma C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle Circulation 107 13 2003 1783 1790 Epub 2003 Mar 17 (Pubitemid 36418360)
115. R.J. Torry, C.A. Labarrere, D.S. Torry, V.J. Holt, and W.P. Faulk Vascular endothelial growth factor expression in transplanted human hearts Transplantation 60 12 1995 1451 1457 (Pubitemid 26012679)
116. X.M. Zhao, T.K. Yeoh, W.H. Frist, D.L. Porterfield, and G.G. Miller Induction of acidic fibroblast growth factor and full-length platelet-derived growth factor expression in human cardiac allografts. Analysis by PCR, in situ hybridization, and immunohistochemistry Circulation 90 2 1994 677 685
117. C.R. Wagner, T.E. Morris, and G.D. Shipley Regulation of human aortic endothelial cell-derived mesenchymal growth factors by allogeneic lymphocytes in vitro J. Clin. Invest. 92 1993 1269 1277
118. X.M. Zhao, Y. Hu, G.G. Miller, R.N. Mitchell, and P. Libby Association of thrombospondin-1 and cardiac allograft vasculopathy in human cardiac allografts Circulation 103 4 2001 525 531 (Pubitemid 32116236)
119. K. Tsukioka, J. Suzuki, M. Kawauchi, Y. Wada, T. Zhang, A. Nishio, N. Koide, M. Endoh, K. Takayama, S. Takamoto, M. Isobe, and J. Amano Expression of membrane-type 1 matrix metalloproteinase in coronary vessels of allotransplanted primate hearts J. Heart Lung Transplant. 19 12 2000 1193 1198
120. M.H. Yamani, E.M. Tuzcu, R.C. Starling, N.B. Ratliff, Y. Yu, D.G. Vince, K. Powell, D. Cook, P. McCarthy, and J.B. Young Myocardial ischemic injury after heart transplantation is associated with upregulation of vitronectin receptor (alpha(v)beta3), activation of the matrix metalloproteinase induction system, and subsequent development of coronary vasculopathy Circulation 105 16 2002 1955 1961 (Pubitemid 34437624)
121. K. Tsukioka, J. Suzuki, M. Fujimori, Y. Wada, K. Yamaura, K. Ito, R. Morishita, Y. Kaneda, M. Isobe, and J. Amano Expression of matrix metalloproteinases in cardiac allograft vasculopathy and its attenuation by anti MMP-2 ribozyme gene transfection Cardiovasc. Res. 56 3 2002 472 478 (Pubitemid 35351569)
122. R.R. Meliss, K. Pethig, A. Schmidt, B. Heublein, W. Harringer, M. Karck, H. Choritz, and A. Haverich Cardiac allograft vasculopathy: adventitial immunoreactivity for PDGF-B and PDGFr-beta in extra-versus intramural coronary arteries Transpl. Proc. 33 1-2 2001 1579 1580 (Pubitemid 32237980)
123. P. Häyry Common pathways in allograft arteriosclerosis and experimental vascular injury: new potential sites of inhibition Transpl. Proc. 30 3 1998 685 686 (Pubitemid 28216764)
124. J.D. Hosenpud, T.E. Morris, G.D. Shipley, K.A. Mauck, and C.R. Wagner Cardiac allograft vasculopathy. Preferential regulation of endothelial cell-derived mesenchymal growth factors in response to a donor-specific cell-mediated allogeneic response Transplantation 61 6 1996 939 948
125. T. Aziz, P. Hasleton, A.W. Hann, N. Yonan, A. Deiraniya, and I.V. Hutchinson Transforming growth factor beta in relation to cardiac allograft vasculopathy after heart transplantation J. Thorac. Cardiovasc. Surg. 119 4 Pt 1 2000 700 708 (Pubitemid 30395467)
126. A. Räisänen-Sokolowski, and P. Häyry Chronic allograft arteriosclerosis: contributing factors and molecular mechanisms in the light of experimental studies Transpl. Immunol. 4 2 1996 91 98 Review (Pubitemid 26334742)
127. H. Lin, J.E. Wilson, C.R. Roberts, K.J. Horley, G.L. Winters, M.R. Costanzo, and B.M. McManus Biglycan, decorin, and versican protein expression patterns in coronary arteriopathy of human cardiac allograft: distinctness as compared to native atherosclerosis J. Heart Lung Transplant. 15 12 1996 1233 1247 (Pubitemid 26428399)
128. R. Ignoltz, and J. Massague Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix J. Biol. Chem. 261 1986 4337 4345 (Pubitemid 17198877)
129. J. Thyberg, K. Blomgren, J. Roy, P.K. Tran, and U. Hedin Phenotypic modulation of smooth muscle cells after arterial injury is associated with changes in the distribution of laminin and fibronectin J. Histochem. Cytochem. 45 6 1997 837 846 (Pubitemid 27248799)
130. J.D. Smith, A.J. Danskine, M.L. Rose, and M.H. Yacoub Specificity of lymphocytotoxic antibodies formed after cardiac transplantation and correlation with rejection episodes Transplantation 53 6 1992 1358 1362
131. G.A. Petrossian, A.B. Nichols, C.C. Marboe, R. Sciacca, E.A. Rose, C.R. Smith, P.J. Cannon, K. Reemtsma, and E.R. Powers Relation between survival and development of coronary artery disease and anti-HLA antibodies after cardiac transplantation Circulation 80 5 Pt 2 1989 III122 III125
132. E.A. Rose, P. Pepino, M.L. Barr, C.R. Smith, A.J. Ratner, E. Ho, and C. Berger Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients J. Heart Lung Transplant. 11 3 Pt 2 1992 S120 S123
133. E.F. Reed, B. Hong, E. Ho, P.E. Harris, J. Weinberger, and N. Suciu-Foca Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease Transplantation 61 4 1996 566 572 (Pubitemid 26073600)
134. E.A. Rose, C.R. Smith, G.A. Petrossian, M.L. Barr, and K. Reemtsma Humoral immune responses after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis Surgery 106 2 1989 203 207 discussion 207-208
135. R. Fredrich, M. Toyoda, L.S. Czer, K. Galfayan, O. Galera, A. Trento, D. Freimark, S. Young, and S.C. Jordan The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation Transplantation 67 3 1999 385 391 (Pubitemid 29094008)
136. T.T. Lim, D.H. Liang, J. Botas, J.S. Schroeder, S.N. Oesterle, and A.C. Yeung Role of compensatory enlargement and shrinkage in transplant coronary artery disease. Serial intravascular ultrasound study Circulation 95 4 1997 855 859 (Pubitemid 27091525)
137. H. Tsutsui, K.M. Ziada, P. Schoenhagen, A. Iyisoy, W.A. Magyar, T.D. Crowe, J.D. Klingensmith, D.G. Vince, G. Rincon, R.E. Hobbs, M. Yamagishi, S.E. Nissen, and E.M. Tuzcu Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study Circulation 104 6 2001 653 657 (Pubitemid 32738518)
138. H. Lou, T. Kodama, and Y.N. Wang l-Arginine prevents heart transplant arteriosclerosis by modulating the vascular cell proliferative response to insulin-like growth factor-I and interleukin-6 J. Heart Lung Transplant. 15 1996 1248
139. M.H. Kown, T. van Der Steenhoven, S. Uemura, C.L. Jahncke, G.E. Hoyt, J.B. Rothbard, and R.C. Robbins l-Arginine polymer mediated inhibition of graft coronary artery disease after cardiac transplantation Transplantation 71 11 2001 1542 1548 (Pubitemid 32574152)
140. J. Koglin, T. Glysing-Jensen, J.S. Mudgett, and M.E. Russell Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice Circulation 97 20 1998 2059 2065 (Pubitemid 28243669)
141. K. Akita, G.J. Dusting, and H. Hickey Suppression of nitric oxide production by cyclosporin A and FK506A in rat vascular smooth muscle cells Clin. Exp. Pharmacol. Physiol. 21 3 1994 231 233 (Pubitemid 24154530)
142. T. Marumo, T. Nakaki, K. Hishikawa, H. Suzuki, R. Kato, and T. Saruta Cyclosporin A inhibits nitric oxide synthase induction in vascular smooth muscle cells Hypertension 25 4 Pt 2 1995 764 768
143. D. Kunz, G. Walker, W. Eberhardt, D. Nitsch, and J. Pfeilschifter Interleukin 1 beta-induced expression of nitric oxide synthase in rat renal mesangial cells is suppressed by cyclosporin A Biochem. Biophys. Res. Commun. 216 2 1995 438 446
144. R.S. Poston, M. Billinggham, G. Hoyt, J. Pollard, R. Morris, and R.C. Robbins Rapamycin reversed chronic graft vascular disease in a novel allograft model Circulation 100 1 1999 67 74 (Pubitemid 29297942)
145. S.M. Pham, L.L. Shears, and N. Kawaharada Rapamycin prevents allograft arteriosclerosis by permitting the endogenous expression on inducible nitric oxide synthase in the allograft Surgical Forum 1997
146. K. Cosby, K.S. Partovi, J.H. Crawford, R.P. Patel, C.D. Reiter, S. Martyr, B.K. Yang, M.A. Waclawiw, G. Zalos, X. Xu, K.T. Huang, H. Shields, D.B. Kim-Shapiro, A.N. Schechter, R.O. Cannon 3rd, and M.T. Gladwin Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation Nat. Med. 9 12 2003 1498 1505 Epub 2003 Nov 2 (Pubitemid 38004777)
147. M. Tanaka, K. Sydow, F. Gunawan, J. Jacobi, P.S. Tsao, R.C. Robbins, and J.P. Cooke Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease Circulation 112 11 2005 1549 1556 Epub 2005 Sep 6 (Pubitemid 41324515)
148. Z. Qian, R. Gelzer-Bell, S.X. Yang Sx, W. Cao, T. Ohnishi, B.A. Wasowska, R.H. Hruban, E.R. Rodriguez, W.M. Baldwin 3rd, and C.J. Lowenstein Inducible nitric oxide synthase inhibition of weibel-palade body release in cardiac transplant rejection Circulation 104 19 2001 2369 2375 (Pubitemid 33049523)
149. L. Potena, W.F. Fearon, K. Sydow, C. Holweg, H. Luikart, C. Chin, D. Weisshaar, E.S. Mocarski, D.B. Lewis, H.A. Valantine, and J.P. Cooke Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus Transplantation 85 6 2008 827 833 (Pubitemid 351447261)
150. L.P. Perrault, O. Malo, J.P. Bidouard, N. Villeneuve, J.P. Vilaine, and P.M. Vanhoutte Inhibiting the NO pathway with intracoronary l-NAME infusion increases endothelial dysfunction and intimal hyperplasia after heart transplantation J. Heart Lung Transplant. 22 4 2003 439 451 (Pubitemid 36390231)
151. S. Kanno, P.K. Kim, K. Sallam, J. Lei, T.R. Billiar, and L.L. Shears 2nd Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells Proc. Natl. Acad. Sci. USA 101 33 2004 12277 12281 (Pubitemid 39145434)
152. C.J. Hall, M.V. Flores, S.H. Oehlers, L.E. Sanderson, E.Y. Lam, K.E. Crosier, and P.S. Crosier Infection-responsive expansion of the hematopoietic stem and progenitor cell compartment in zebrafish is dependent upon inducible nitric oxide Cell Stem Cell 10 2 2012 198 209
153. M.R. Kibbe, J. Li, S. Nie, S.C. Watkins, A. Lizonova, I. Kovesdi, R.L. Simmons, T.R. Billiar, and E. Tzeng Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate J. Vasc. Surg. 31 6 2000 1214 1228 (Pubitemid 30418493)
154. S. Ambs, W.G. Merriam, M.O. Ogunfusika, W.P. Bennett, N. Ishibe, S.P. Hussain, E.E. Tzeng, D.A. Geller, T.R. Billiar, and C.C. Harris P53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells Nat. Med. 4 12 1998 1371 1376 (Pubitemid 28553458)
155. N.D. Tsihlis, J. Murar, M.R. Kapadia, S.S. Ahanchi, C.S. Oustwani, J.E. Saavedra, L.K. Keefer, and M.R. Kibbe Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury J. Vasc. Surg. 51 5 2010 1248 1259
156. G.E. Havelka, E.S. Moreira, M.P. Rodriguez, N.D. Tsihlis, Z. Wang, J. Martínez, J.A. Hrabie, L.K. Kiefer, and M.R. Kibbe Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury J. Surg. Res. 180 1 2013 35 42
157. T.L. Brunton On the use of nitrite of amyl in angina pectoris Lancet 1867 97 98
158. S. Weiss, R.W. Wilkins, and F.W. Haynes The nature of circulatory collapse induced by sodium nitrite J. Clin. Invest. 16 1 1937 73 84
159. J.L. Zweier, P. Wang, A. Samouilov, and P. Kuppusamy Enzyme-independent formation of nitric oxide in biological tissues Nat. Med. 1 8 1995 804 809
160. T.M. Millar, C.R. Stevens, N. Benjamin, R. Eisenthal, R. Harrison, and D.R. Blake Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions FEBS Lett. 427 2 1998 225 228 (Pubitemid 28225062)
161. Z. Zhang, D. Naughton, P.G. Winyard, N. Benjamin, D.R. Blake, and M.C. Symons Generation of nitric oxide by a nitrite reductase activity of xanthine oxidase: a potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity Biochem. Biophys. Res. Commun. 249 3 1998 767 772 (Pubitemid 28441913)
162. A.M. Badejo Jr, C. Hodnette, J.S. Dhaliwal, D.B. Casey, E. Pankey, S.N. Murthy, B.D. Nossaman, A.L. Hyman, and P.J. Kadowitz Mitochondrial aldehyde dehydrogenase mediates vasodilator responses of glyceryl trinitrate and sodium nitrite in the pulmonary vascular bed of the rat Am. J. Physiol. Heart Circ. Physiol. 299 3 2010 H819 H826
163. D.B. Casey, A.M. Badejo Jr., J.S. Dhaliwal, S.N. Murthy, A.L. Hyman, B.D. Nossaman, and P.J. Kadowitz Pulmonary vasodilator responses to sodium nitrite are mediated by an allopurinol-sensitive mechanism in the rat Am. J. Physiol. Heart Circ. Physiol. 296 2 2009 H524 H533
164. T.O. Nossuli, R. Hayward, D. Jensen, R. Scalia, and A.M. Lefer Mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury Am. J. Physiol. 275 2 Pt 2 1998 H509 H519
165. T.O. Nossuli, R. Hayward, R. Scalia, and A.M. Lefer Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats Circulation 96 7 1997 2317 2324 (Pubitemid 27425839)
166. D.J. Lefer, R. Scalia, B. Campbell, T. Nossuli, R. Hayward, M. Salamon, J. Grayson, and A.M. Lefer Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats J. Clin. Invest. 99 4 1997 684 691 (Pubitemid 27097670)
167. D.B. Casey, E.A. Pankey, A.M. Badejo, F.R. Bueno, M. Bhartiya, S.N. Murthy, R.M. Uppu, B.D. Nossaman, and P.J. Kadowitz Peroxynitrite has potent pulmonary vasodilator activity in the rat Can. J. Physiol. Pharmacol. 90 4 2012 485 500
168. B.S. Zuckerbraun, D.A. Stoyanovsky, R. Sengupta, R.A. Shapiro, B.A. Ozanich, J. Rao, J.E. Barbato, and E. Tzeng Role of p42/p44 mitogen-activated- protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide Am. J. Physiol. Cell Physiol. 292 2 2007 C824 C831
169. M.F. Olson, H.F. Paterson, and C.J. Marshall Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1 Nature 394 6690 1998 295 299 (Pubitemid 28335044)
170. D.V. Young, D. Serebryanik, D.R. Janero, and S.W. Tam Suppression of proliferation of human coronary artery smooth muscle cells by the nitric oxide donor, S-nitrosoglutathione, is cGMP-independent Mol. Cell. Biol. Res. Commun. 4 1 2000 32 36
171. P.M. Bauer, G.M. Buga, and L.J. Ignarro Role of p42/p44 mitogen-activated-protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide Proc. Natl. Acad. Sci. USA 98 22 2001 12802 12807 (Pubitemid 33020025)
172. A. Papapetropoulos, K.M. Desai, R.D. Rudic, B. Mayer, R. Zhang, M.P. Ruiz-Torres, G. García-Cardeña, J.A. Madri, and W.C. Sessa Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro Am. J. Pathol. 150 5 1997 1835 1844 (Pubitemid 27193829)
173. Z.S. Galis, C. Johnson, D. Godin, R. Magid, J.M. Shipley, R.M. Senior, and E. Ivan Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling Circ. Res. 91 9 2002 852 859 (Pubitemid 35285084)
174. A. Cho, and M.A. Reidy Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury Circ. Res. 91 9 2002 845 851 (Pubitemid 35285083)
175. D.P. Mason, R.D. Kenagy, D. Hasenstab, D.F. Bowen-Pope, R.A. Seifert, S. Coats, S.M. Hawkins, and A.W. Clowes Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery Circ. Res. 85 12 1999 1179 1185 (Pubitemid 30430623)
176. C. Johnson, and Z.S. Galis Matrix metalloproteinase-2 and -9 differentially regulate smooth musclecell migration and cell-mediated collagen organization Arterioscler. Thromb. Vasc. Biol. 24 1 2004 54 60 (Pubitemid 38082411)
177. S. Xu, A.S. Shriver, D.K. Jagadeesha, A.H. Chamseddine, K. Szocs, N.L. Weintraub, K.K. Griendling, R.C. Bhalla, and F.J. Miller Jr. Increased expression of Nox1 in neointimal smooth muscle cells promotes activation of matrix metalloproteinase-9 J. Vasc. Res. 49 3 2012 242 248
178. H. Wang, C. Liu, Y. Song, D. Gordon, M.Z. Alavi, and S. Moore Expression of metalloproteinases and its inhibitor in later stage of rabbit neointima development Int. J. Mol. Med. 7 1 2001 105 112
179. M.V. Gurjar, J. DeLeon, R.V. Sharma, and R.C. Bhalla Mechanism of inhibition of matrix metalloproteinase-9 induction by NO in vascular smooth muscle cells J. Appl. Physiol. 91 3 2001 1380 1386 (Pubitemid 32803936)
180. M.V. Gurjar, R.V. Sharma, and R.C. Bhalla ENOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity Arterioscler. Thromb. Vasc. Biol. 19 12 1999 2871 2877 (Pubitemid 30029812)
181. A.M. Wilson, R. Harada, N. Nair, N. Balasubramanian, and J.P. Cooke l-Arginine supplementation in peripheral arterial disease: no benefit and possible harm Circulation 116 2 2007 188 195 (Pubitemid 47057525)
182. C. Letizia, L. De Biase, C. Caliumi, C. Verrelli, R. Semeraro, S. Subioli, S. Cerci, and E. D'Erasmo Endothelin-1 circulating levels increase in patients with orthotopic heart transplantation and in chronic therapy with cyclosporine Minerva Cardioangiol. 49 1 2001 15 22 (Pubitemid 32318778)
183. D. Ramzy, V. Rao, L.C. Tumiati, N. Xu, S. Miriuka, D. Delgado, and H.J. Ross Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine Circulation 114 1 Suppl. 2006 I214 1219
184. G.J. Haas, M. Wooding-Scott, P.F. Binkley, P.D. Myerowitz, R. Kelley, and R.J. Cody Effects of successful cardiac transplantation on plasma endothelin Am. J. Cardiol. 71 2 1993 237 240 (Pubitemid 23030650)
185. K. Sudhir, T. DeMarco, S. Kumar, K. Maganti, T.M. Amidon, C.J. de Groot, C. Klinski, D. Lau, F. Keith, and R.N. Taylor Transcoronary and pulmonary vascular dynamics of endothelin-1 in heart transplant recipients J. Heart Lung Transplant. 14 2 1995 230 235
186. M.S. Simonson, A.V. Robinson, J.A. Schulak, and D.E. Hricik Inhibition of endothelin-1 improves survival and vasculopathy in rat cardiac transplants treated with cyclosporine Transplantation 73 7 2002 1054 1059 (Pubitemid 34415434)
187. D. Fulton, J.P. Gratton, T.J. McCabe, J. Fontana, Y. Fujio, K. Walsh, T.F. Franke, A. Papapetropoulos, and W.C. Sessa Regulation of endothelium-derived nitric oxide production by the protein kinase Akt Nature 399 6736 1999 597 601
188. S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse, and A.M. Zeiher Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation Nature 399 6736 1999 601 605
189. B.J. Michell, M.B. Harris, Z.P. Chen, H. Ju, V.J. Venema, M.A. Blackstone, W. Huang, R.C. Venema, and B.E. Kemp Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635 J. Biol. Chem. 277 44 2002 42344 42351 (Pubitemid 35257555)
190. D. Fulton, L. Ruan, S.G. Sood, C. Li, Q. Zhang, and R.C. Venema Agonist-stimulated endothelial nitric oxide synthase activation and vascular relaxation. Role of eNOS phosphorylation at Tyr83 Circ. Res. 102 4 2008 497 504 (Pubitemid 351651107)
191. C. Li, L. Ruan, S.G. Sood, A. Papapetropoulos, D. Fulton, and R.C. Venema Role of eNOS phosphorylation at Ser-116 in regulation of eNOS activity in endothelial cells Vascul. Pharmacol. 47 5-6 2007 257 264 (Pubitemid 350017809)
192. F.J. Klinz, A. Schmidt, T. Schinköthe, S. Arnhold, B. Desai, F. Popken, K. Brixius, R. Schwinger, U. Mehlhorn, P. Staib, K. Addicks, and W. Bloch Phospho-eNOS Ser-114 in human mesenchymal stem cells: constitutive phosphorylation, nuclear localization and upregulation during mitosis Eur. J. Cell Biol. 84 10 2005 809 818 (Pubitemid 41440013)
193. I. Fleming, B. Fisslthaler, S. Dimmeler, B.E. Kemp, and R. Busse Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity Circ. Res. 88 11 2001 E68 E75
194. B. Fisslthaler, A.E. Loot, A. Mohamed, R. Busse, and I. Fleming Inhibition of endothelial nitric oxide synthase activity by proline-rich tyrosine kinase 2 in response to fluid shear stress and insulin Circ. Res. 102 12 2008 1520 1528
195. S. Gingerich, and T.L. Krukoff Activation of ERbeta increases levels of phosphorylated nNOS and NO production through a Src/PI3K/Akt-dependent pathway in hypothalamic neurons Neuropharmacology 55 5 2008 878 885
196. Z.P. Chen, G.K. McConell, B.J. Michell, R.J. Snow, B.J. Canny, and B.E. Kemp AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation Am. J. Physiol. Endocrinol. Metab. 279 5 2000 E1202 E1206
197. Y. Hayashi, M. Nishio, Y. Naito, H. Yokokura, Y. Nimura, H. Hidaka, and Y. Watanabe Regulation of neuronal nitric-oxide synthase by calmodulin kinases J. Biol. Chem. 274 29 1999 20597 20602
198. T. Song, N. Hatano, M. Horii, H. Tokumitsu, F. Yamaguchi, M. Tokuda, and Y. Watanabe Calcium/calmodulin-dependent protein kinase I inhibits neuronal nitric-oxide synthase activity through serine 741 phosphorylation FEBS Lett. 570 1-3 2004 133 137 (Pubitemid 38900970)
199. T. Song, N. Hatano, K. Kume, K. Sugimoto, F. Yamaguchi, M. Tokuda, and Y. Watanabe Inhibition of neuronal nitric-oxide synthase by phosphorylation at Threonine1296 in NG108-15 neuronal cells FEBS Lett. 579 25 2005 5658 5662 (Pubitemid 41455645)
200. Y. Zhang, V. Brovkovych, S. Brovkovych, F. Tan, B.S. Lee, T. Sharma, and R.A. Skidgel Dynamic receptor-dependent activation of inducible nitric-oxide synthase by ERK-mediated phosphorylation of Ser745 J. Biol. Chem. 282 44 2007 32453 32461 (Pubitemid 350106477)
201. A. Tyryshkin, F.M. Gorgun, E. Abdel Fattah, T. Mazumdar, L. Pandit, S. Zeng, and N.T. Eissa Src kinase-mediated phosphorylation stabilizes inducible nitric-oxide synthase in normal cells and cancer cells J. Biol. Chem. 285 1 2010 784 792
202. P. Hausel, H. Latado, F. Courjault-Gautier, and E. Felley-Bosco Src-mediated phosphorylation regulates subcellular distribution and activity of human inducible nitric oxide synthase Oncogene 25 2 2006 198 206 (Pubitemid 43083681)
203. H.E. Van Wart, and H. Birkedal-Hansen The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family Proc. Natl. Acad. Sci. USA 87 14 1990 5578 5582